Christian Schulze: Time to Say Good-Bye to The “Obesity Paradox”?
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn:
”Microvascular dysfunction is a remaining diagnostic and therapeutic challenge in ACS.
We show that an increased BMI has been associated with microvascular dysfunction after NSTEMI.
BMI above 25.6 kg/m² is an independent predictors of microvascular dysfunction.
Time to say good-bye to the “obesity paradox”?
Congrats to the TATORT-NSTEMI investigators!”
Read the full article here.
Article: Overweight predisposes to microvascular obstruction: insights from the TATORT-NSTEMI trial
Authors: Felix Troger, Ingo Eitel, Roza Saraei, Thomas Stiermaier, Michael Böhm, Bernward Lauer, P Christian Schulze, Tobias Geisler, Leonhard Bruch, Norbert Klein, Uwe Zeymer, Agnes Mayr, Maria Buske, Steffen Desch, Holger Thiele, Hans-Josef Feistritzer
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 23, 2026, 16:46Soumya Mukherjee on Amyloid-β Isoform Modifications in CAA and Alzheimer’s
-
Jan 23, 2026, 16:32Amit Srivastava Edits The New Springer Protocols Volume on Extracellular Vesicles
-
Jan 23, 2026, 14:42David Stegner on PITTs Exacerbating Severe Inflammation
-
Jan 23, 2026, 14:16Ahmed Nasreldein In The 1st Podcast Episode of International Journal of Stroke
-
Jan 23, 2026, 13:53Omar Shaltout: When Hematology Meets Gastroenterology in the ICU
-
Jan 23, 2026, 13:39Harshal Kale Invites You to WFH Webinar on World Health Assembly Resolution on Bleeding Disorders
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones